blood cancer News
Most Popular blood cancer Story
Novartis maps out a blockbuster future for INC424
With a solid set of favorable late-stage data from two Phase III trials in its hands, Novartis ($NVS) has mapped out a relatively short path to blockbuster status for the experimental cancer drug Read more...
Latest Headlines
- December 9, 2011
- November 29, 2011
- March 16, 2011
- December 21, 2010
- December 9, 2008
- August 20, 2008
- December 11, 2007
- November 19, 2007
- August 31, 2007
- September 26, 2006
- June 29, 2006
- May 25, 2006
- April 9, 2006
- January 22, 2006
- January 8, 2006
- July 25, 2005
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
